If there are some positives from the current trials, does this FDA proposal, which has a 60 day comment period, accelerate the traectory of PBT? Does it lessen the requirements for a phase 111 before approvals?
- Forums
- ASX - By Stock
- ATH
- fda proposes to lower the bar on alzheimer's d
fda proposes to lower the bar on alzheimer's d, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $200 | 66.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 75258609 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 5286356 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
54 | 75258609 | 0.002 |
23 | 117810099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 5286356 | 4 |
0.004 | 132321201 | 25 |
0.005 | 25242406 | 26 |
0.006 | 23031950 | 19 |
0.007 | 47726651 | 22 |
Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |